The PD-L1 transmembrane protein is known to express on the surface of CRC, and its binding with PD-1 leads to the escape of cancer cells from immune-mediated destruction, thereby enhancing cancer cell growth (7). The gene discussed is PDCD1; the disease is colorectal carcinoma.